Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-News: MEDICLIN buys Reha-Klinik am Sendesaal
EQS-News: MEDICLIN buys Reha-Klinik am Sendesaal
EQS-News: MEDICLIN buys Reha-Klinik am Sendesaal
Agilent Brings Great Science to Life at Analytica 2024:
Agilent Brings Great Science to Life at Analytica 2024


Agilent Technologies Inc. (NYSE: A) today announced its participation in Analytica 2024, where it will unveil its latest innovations and transformative workflows. Analytica, the premier

U.S. FDA Renews DILIsym® Software Licenses for 7th Year: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
U.S. FDA Renews DILIsym® Software Licenses for 7th Year


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that

STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024: https://mms.businesswire.com/media/20200413005098/en/683092/5/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg
STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today

Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results


Simulations Plus, Inc. (NASDAQ: SLP) (“Simulations Plus”), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial

Acadia Healthcare Announces Date for First Quarter 2024 Earnings Release: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare Announces Date for First Quarter 2024 Earnings Release


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its first quarter 2024 results on Wednesday, May 1, 2024, after the close of the market. Acadia will conduct a

Dexcom Publishes Annual Sustainability Report: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Publishes Annual Sustainability Report


DexCom, Inc. (NASDAQ:DXCM), the leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today released its annual Sustainability Report. This report provides updates on

Agilent at AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics:
Humana Healthy Horizons – Ohio partners with CPESN® USA to expand access to pharmacists: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana Healthy Horizons – Ohio partners with CPESN® USA to expand access to pharmacists


Humana Healthy Horizons, the Medicaid business of leading health and well-being company Humana, announced it is partnering with CPESN® USA in Ohio to expand access to pharmacists for its members

Acadia Healthcare Accelerates Access to Care With Uber Health: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare Accelerates Access to Care With Uber Health


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced a collaboration with Uber Health (NYSE:UBER). The two companies are coming together to improve access to life-saving behavioral health

Agilent and UC San Diego Launch Center of Excellence in Cellular Intelligence:
Agilent and UC San Diego Launch Center of Excellence in Cellular Intelligence


Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, and the University of California San Diego (UC San Diego), one of the top-ranked

Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time


DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2024 financial results after market close on Thursday, April 25, 2024. Management will hold a conference call

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO  THE NUMBER OF SHARES AND VOTING RIGHTS  MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Chemed To Report First-Quarter 2024 Earnings April 24, Related Conference Call To Be Held On April 25:
Chemed To Report First-Quarter 2024 Earnings April 24, Related Conference Call To Be Held On April 25


Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the first quarter ended March 31, 2024, on Wednesday, April 24, 2024, following the close of trading on the

Agilent Launches New Advanced Dilution System to Increase Lab Efficiency:
Agilent Launches New Advanced Dilution System to Increase Lab Efficiency


Agilent Technologies Inc. (NYSE: A) today announced the launch of the Advanced Dilution System, the ADS 2, a new automation workflow solution that will increase productivity, lower cost of

Acadia Healthcare Acquires Three Comprehensive Treatment Centers in North Carolina: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare Acquires Three Comprehensive Treatment Centers in North Carolina


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it has recently completed the acquisitions of three comprehensive treatment centers (“CTC”) in North Carolina.



Two of the

EQS-News: MEDICLIN Herzzentrum Coswig: Transfer of operations on 1 April
EQS-News: MEDICLIN Herzzentrum Coswig: Transfer of operations on 1 April
EQS-News: MEDICLIN Herzzentrum Coswig: Transfer of operations on 1 April
Resolutions of the Annual Shareholders’ Meeting  of Sartorius Stedim Biotech S.A.
Resolutions of the Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.
Resolutions of the Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.
EQS-News: MEDICLIN achieves consolidated Group sales of EUR 730.1 million in 2023 - outlook for 2024 is positive
EQS-News: MEDICLIN achieves consolidated Group sales of EUR 730.1 million in 2023 - outlook for 2024 is positive
EQS-News: MEDICLIN achieves consolidated Group sales of EUR 730.1 million in 2023 - outlook for 2024 is positive
Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference: https://mms.businesswire.com/media/20220804005173/en/622619/5/Inogen_Logo_300_DPI.jpg
Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced management will participate in the 23rd Annual

EQS-News: MEDICLIN plans to buy Reha-Klinik am Sendesaal
EQS-News: MEDICLIN plans to buy Reha-Klinik am Sendesaal
EQS-News: MEDICLIN plans to buy Reha-Klinik am Sendesaal
EQS-News: Eckert & Ziegler Continues on Growth Path after Successful Financial Year 2023
EQS-News: Eckert & Ziegler Continues on Growth Path after Successful Financial Year 2023
EQS-News: Eckert & Ziegler Continues on Growth Path after Successful Financial Year 2023
EQS-News: MEDICLIN invites you to the virtual press conference  on the financial statements for the year 2023
EQS-News: MEDICLIN invites you to the virtual press conference on the financial statements for the year 2023
EQS-News: MEDICLIN invites you to the virtual press conference on the financial statements for the year 2023
LivaNova to Announce First-Quarter 2024 Results: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova to Announce First-Quarter 2024 Results


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its first-quarter 2024 results on Wednesday, May 1, 2024 at 1 p.m. London time (8

EQS-News: Eckert & Ziegler Receives MDR Certification for Prostate Seeds, Paving the Way for Long-term Supply
EQS-News: Eckert & Ziegler Receives MDR Certification for Prostate Seeds, Paving the Way for Long-term Supply
EQS-News: Eckert & Ziegler Receives MDR Certification for Prostate Seeds, Paving the Way for Long-term Supply